SSKN — STRATA Skin Sciences Balance Sheet
0.000.00%
- $8.48m
- $16.71m
- $33.56m
Annual balance sheet for STRATA Skin Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 10.6 | 12.6 | 5.43 | 6.78 | 7.26 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.94 | 3.43 | 4.47 | 4.44 | 5.25 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 24.8 | 20 | 15.1 | 15.5 | 16.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6.52 | 7.52 | 10.9 | 12.4 | 11.3 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 46.8 | 46.6 | 52.3 | 42 | 36.2 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 18.8 | 12.8 | 13.4 | 12.2 | 14.6 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 20.9 | 21.2 | 30.4 | 29.3 | 31.2 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 25.9 | 25.4 | 21.8 | 12.7 | 4.97 |
| Total Liabilities & Shareholders' Equity | 46.8 | 46.6 | 52.3 | 42 | 36.2 |
| Total Common Shares Outstanding |